Abstract
This review is based on a Mallinckrodt Pharmaceuticals-sponsored presentation, "The Delicate Balance of Managing Oxygen Treatment in Neonates," delivered by Amy R Koehn, PhD, NNP-BC, at the National Association of Neonatal Nurses (NANN) 33rd Annual Conference, held in Providence, Rhode Island on October 11, 2017. In addition to focusing on the potential risks associated with exposing newborn tissues to episodes of lower (hypoxic) and higher (hyperoxic) than normal concentrations of serum oxygen, the current guidance for target saturation ranges and methods of tissue oxygenation measurements in neonates was reviewed. A total of 181 neonatal nurses, neonatal nurse practitioners, nurse educators, and nurse managers were polled during the presentation using an audience response system (ARS). Results from this poll and two similar polls from previous years are discussed.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
